Feb 26, 2019 - Top drug companies addressed sky-high drug prices on Capitol Hill today.
Feb 26, 2019 - Roche's big step into the gene-editing space will spark interest for these two stocks.
Feb 13, 2019 - Ascendis Pharma (ASND) submits regulatory application to initiate a phase II study in the United States on its hypoparathyroidism therapy candidate, TransCon PTH.
Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
Feb 08, 2019 - Alnylam (ALNY) incurs wider year-over-year loss in the fourth quarter of 2018.
Feb 07, 2019 -
Feb 07, 2019 - Sanofi (SNY) beat estimates for earnings and missed the same for sales in the fourth quarter. The Specialty Care unit drove top-line growth.
Feb 06, 2019 - Regeneron's (REGN) earnings and sales surpass expectations in Q4 on solid Dupixent and Eylea sales.
Feb 06, 2019 - The Zacks Analyst Blog Highlights: Pepsico, Disney, Sanofi, Diageo and HCA
Feb 06, 2019 - Top Ranked Income Stocks to Buy for February 6th